logo
PayPal Unveils Another Credit Card for In-Person Shopping Push

PayPal Unveils Another Credit Card for In-Person Shopping Push

Bloomberg03-06-2025

PayPal Holdings Inc. is adding a new card to bring its online credit product to physical stores as the company focuses on expanding its name recognition with in-person transactions.
The new PayPal credit card joins the San Jose, California-based company's debit card, introduced more than two decades ago, and a separate 3% cash-back credit card. The new credit card, issued by Synchrony Financial, will launch with a six-month promotion offering no-interest financing for qualifying travel purchases including flights and hotels, according to a statement.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jony Ive's First AI Gadget? Clues Point to a Pen
Jony Ive's First AI Gadget? Clues Point to a Pen

Bloomberg

timean hour ago

  • Bloomberg

Jony Ive's First AI Gadget? Clues Point to a Pen

The hottest new collaboration in Silicon Valley is between OpenAI Chief Executive Officer Sam Altman and Jony Ive, the former Apple Inc. designer credited with giving iPhones, Macs and AirPods their sleek, covetous look. Altman bought Ive's startup for $6.5 billion earlier this year, releasing a slickly produced video to tease a new 'family' of devices that would let people 'use AI to create all sorts of wonderful things.' OpenAI has kept its plans a secret, but here's what we know: The first so-called AI device won't have a screen and it won't be something you can wear, according to recent filings in an unrelated court case. It probably won't look anything like the Humane Pin, a pioneering AI gadget that failed spectacularly. So what will it be? My money is on a pen.

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

Associated Press

timean hour ago

  • Associated Press

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

BASEL, Switzerland--(BUSINESS WIRE)--Jun 30, 2025-- Syngenta is accelerating the rollout of its nature-inspired, science-based biological solutions, responding to rising demand for sustainable, high-performance tools that help farmers boost productivity efficiently and responsibly. It also contributes toward Syngenta's fulfilment of commitments outlined in its Sustainability Priorities. Jonathan Brown, Global Head Biologicals & Seedcare, comments: 'With our recent partnerships and acquisitions and extended manufacturing capacities, Syngenta is positioning itself as the leader in biologicals. Our scientific expertise is at the forefront of our research and development efforts to provide farmers with the next generation of biologicals, helping them transition towards more sustainable farming practices, such as regenerative agriculture.' In December 2024, the company acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient-use efficiency products. Most recently, in early 2025, Syngenta concluded the integration of Novartis' Strains and Natural Products Collection, the repository of natural compounds and genetic strains for agricultural use. These additions will accelerate the development of biologicals, bringing new tools to the market as a sustainable complement to conventional crop protection solutions. Also in 2025, Syngenta opened a 22,000 m² biologicals facility in Orangeburg, South Carolina, in the United States, which is purpose-built to produce 16,000 tons of biostimulants annually. This new manufacturing facility complements Syngenta's existing global network of biologicals' manufacturing facilities in Brazil, Italy, India and Norway. These strategic milestones effectively enhance both Syngenta's R&D, operating out of the centers of excellence in Stein, Switzerland; Jealott's Hill, UK; Atessa, Italy; and production capacity for biologicals, facilitating Syngenta's roll out of its biologicals pipeline, with multiple candidates demonstrating strong commercial potential with projected annual sales above USD 100 million. Syngenta Biologicals posted strong Q1 2025 results, with standout performance in North America and China. The global biologicals market is growing at around 10% CAGR and is projected to reach nearly USD 20 billion by 2030, according to AgbioInvestor and Syngenta's estimate, underlining the pivotal role of biologicals in the future of sustainable farming. Derived predominantly from naturally occurring substances, biologicals offer significant potential for sustainable agriculture. The market can be categorized into three main categories: About Syngenta Syngenta is a global leader in agricultural innovation with a presence in more than 90 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world's population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X. Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ('legitimate interest'). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement. Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors. ©2025 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland. View source version on CONTACT: Media Contacts Syngenta Media Relations [email protected] Web Resources Pictures KEYWORD: EUROPE SWITZERLAND ASIA PACIFIC INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE AGRICULTURE BIOTECHNOLOGY RESEARCH NATURAL RESOURCES HEALTH OTHER NATURAL RESOURCES SOURCE: Syngenta Copyright Business Wire 2025. PUB: 06/30/2025 02:00 AM/DISC: 06/30/2025 02:00 AM

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

Business Wire

timean hour ago

  • Business Wire

Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers

BASEL, Switzerland--(BUSINESS WIRE)--Syngenta is accelerating the rollout of its nature-inspired, science-based biological solutions, responding to rising demand for sustainable, high-performance tools that help farmers boost productivity efficiently and responsibly. It also contributes toward Syngenta's fulfilment of commitments outlined in its Sustainability Priorities. Jonathan Brown, Global Head Biologicals & Seedcare, comments: 'With our recent partnerships and acquisitions and extended manufacturing capacities, Syngenta is positioning itself as the leader in biologicals. Our scientific expertise is at the forefront of our research and development efforts to provide farmers with the next generation of biologicals, helping them transition towards more sustainable farming practices, such as regenerative agriculture.' In December 2024, the company acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient-use efficiency products. Most recently, in early 2025, Syngenta concluded the integration of Novartis' Strains and Natural Products Collection, the repository of natural compounds and genetic strains for agricultural use. These additions will accelerate the development of biologicals, bringing new tools to the market as a sustainable complement to conventional crop protection solutions. Also in 2025, Syngenta opened a 22,000 m² biologicals facility in Orangeburg, South Carolina, in the United States, which is purpose-built to produce 16,000 tons of biostimulants annually. This new manufacturing facility complements Syngenta's existing global network of biologicals' manufacturing facilities in Brazil, Italy, India and Norway. These strategic milestones effectively enhance both Syngenta's R&D, operating out of the centers of excellence in Stein, Switzerland; Jealott's Hill, UK; Atessa, Italy; and production capacity for biologicals, facilitating Syngenta's roll out of its biologicals pipeline, with multiple candidates demonstrating strong commercial potential with projected annual sales above USD 100 million. Syngenta Biologicals posted strong Q1 2025 results, with standout performance in North America and China. The global biologicals market is growing at around 10% CAGR and is projected to reach nearly USD 20 billion by 2030, according to AgbioInvestor and Syngenta's estimate, underlining the pivotal role of biologicals in the future of sustainable farming. Derived predominantly from naturally occurring substances, biologicals offer significant potential for sustainable agriculture. The market can be categorized into three main categories: Biocontrols – Naturally derived products for managing pests, diseases, and weeds. Biostimulants – Products enhancing natural plant processes to improve abiotic stress tolerance and crop quality. Nutrient Use Efficiency (NUE) products – Any substance or microorganism to improve macro- and micronutrient availability and uptake to promote growth and enhance yield. About Syngenta Syngenta is a global leader in agricultural innovation with a presence in more than 90 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world's population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X. Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ('legitimate interest'). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement. Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors. ©2025 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store